Molecular Testing in Metastatic Gastric/GEJ Cancer
3 Tampilan
• 06/30/23
0
0
Menanamkan
administrator
Pelanggan
David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru